PF-08046054 by Pfizer for Melanoma: Likelihood of Approval

PF-08046054 is under clinical development by Pfizer and currently in Phase I for Melanoma.

Health Equity Gets Boost from Biosimilars and Evidence-Based Treatment

Dr. Minh Huynh, Medical Director at NantHealth Eliminating healthcare inequities requires addressing the underlying social and economic factors that contribute to these disparities and ensuring

August 2, 2023

Opinion | How to Prevent Violence Against Healthcare Workers

Emily Hutto is an Associate Video Producer & Editor for MedPage Today. She is based in Manhattan. Jeremy Faust is editor-in-chief of , an emergency

December 16, 2023

Medtronic cancels $738 million acquisition of diabetes tech company EOFlow

Medtronic is no longer buying EOFlow, a Korean maker of wearable insulin pumps. The news comes three months after Insulet, EOFlow’s rival, filed a lawsuit

December 7, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.